T. Rowe Price Associates’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.5M | Buy |
|
|||||
|
2025
Q2 | $28M | Buy |
|
|||||
|
2025
Q1 | $7.44M | Buy |
|
|||||
|
2024
Q4 | $10.5M | Buy |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $8.41M | Sell |
|
|||||
|
2024
Q1 | $21.5M | Buy |
|
|||||
|
2023
Q4 | $6M | Buy |
|
|||||
|
2023
Q3 | $274K | Sell |
|
|||||
|
2023
Q2 | $490K | Buy |
|
|||||
|
2023
Q1 | $339K | Hold |
|
|||||
|
2022
Q4 | $350K | Hold |
|
|||||
|
2022
Q3 | $191K | Buy |
|
|||||
|
2022
Q2 | $235K | Sell |
|
|||||
|
2022
Q1 | $340K | Buy |
|
|||||
|
2021
Q4 | $702K | Buy |
|